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Olivier Hartung, Pierre Barthelemy, Dominique Arnoux, Mourad Boufi, Yves
S. Alimi
Background: Ilio-caval stenting now represents the first line treatment for
disabling obstructive ilio-caval lesions. Most patients are young women of
child-bearing age. We herein report our experience of pregnancy in women
who have a history of ilio-caval stenting.
Materials and Methods: From November 1995 to April 2008, 119 patients
had ilio-caval stenting for obstructive venous disease in our department.
Of these, 62 women were able to become pregnant. When pregnancy
occurred, they received preventive treatment with low molecular weight
heparin (LMWH) from the 3rd month of pregnancy to 1 month after delivery
and had to wear elastic stockings. Patients also had to sleep on their right
side if possible. They were followed during the pregnancy by duplex
scanning at 3, 6, and 8 months, and then 1 month after delivery.
Results: Eight pregnancies occurred in 6 patients (mean age 26.5 years) who
had a patent self-expanding stent (1 patient had 3 pregnancies). They had
stenting for May-Thurner disease in 3 patients, for post-deep veinous throm-
bosis (DVT) left common iliac vein occlusion in 1 patient, and during venous
thrombectomy in 2 patients. All stents were self-expanding metallic stents
located on the left common iliac vein. One patient had unrelated sponta-
neous abortion after 2 months of pregnancy. No DVT or symptomatic pulmo-
nary embolism occurred during pregnancy, delivery, or during the
postpartum period. Four patients needed cesarean delivery and none had
hemorrhagic complications. None of the patients had adverse effects from
the treatment. Duplex scan showed compression of the stent(s) at 8 months
in 4 patients with inflow obstruction in 3 patients. Postpartum duplex-scan
showed no remaining stenosis in all patients. No stents had structural
damage.
Conclusion: Ilio-caval stent compression can occur during pregnancy but
does not lead to structural damage to the self-expanding stents. Despite
this, no cases of DVT occurred with preventive LMWH treatment.Proposed duplex velocity criteria for carotid restenosis following carotid
endarterectomy with patch closure
Ali F. AbuRahma, Patrick Stone, Samuel Deem, L. Scott Dean, Tammi Keiffer,
Emily Deem
Background: Duplex ultrasound velocity criteria have been used to evaluate
the severity of carotid stenosis, however, these standard velocities may not
be applicable to carotid restenosis after carotid endarterectomy (CEA) with
patch angioplasty. The purpose of this study is to determine if patch angio-
plasty closure alters velocities just distal to CEA and to define the optimal
velocities for detecting 30%, 50%, and 70% restenosis.
Methods: This study includes 200 CEAs randomized into 100 with polytetra-
fluoroethylene (PTFE) ACUSEAL patch and 100 with Hemashield Finesse
patch. All patients underwent immediate postoperative duplex ultrasounds,* Full articles available online at www.jvascsurg.org
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doi:10.1016/S1078-5884(09)00329-3which were repeated at 1 month and every 6 months thereafter. Patients
with a peak systolic velocity (PSV) of the internal carotid artery ([ICA], just
distal to the patch) of 130 c/s underwent CTA. PSVs, end diastolic veloci-
ties (EDV), and internal carotid artery/common carotid artery (ICA/CCA)
ratios were correlated to completion arteriograms/CTAs. Receiver operator
characteristic curves analyses were used to determine optimal velocity
criteria in detecting 30%, 50%, and 70% restenosis.
Results: One hundred ninety-five pairs of imagings (duplex ultrasound vs
CTA/angiogram) were available for analysis. When standard velocity criteria
for nonoperated arteries were applied, 37% and 10% of patients were
believed to have 50% to <70% and 70% to 99% restenosis vs 11.3% and
11.3% on CTA/angiography, respectively (P < .001). The mean PSV for
30%, 50%, and 70% restenosis were 172, 249, and 389 c/s, respectively
(P < .001). An ICA PSV of 155c/s was optimal for 30% restenosis with
sensitivity, specificity, positive predictive value (PPV), negative predictive
value (NPV), and overall accuracy (OA) of 98%, 98%, 98%, 98%, and 98%,
respectively. A PSV of 213 c/s was optimal for 50% restenosis with sensi-
tivity, specificity, PPV, NPV, and OA of 99%, 100%, 100%, 98%, and 99%,
respectively. An ICA PSV of 274 c/s was optimal for 70% restenosis with
sensitivity, specificity, PPV, NPV, and OA of 99%, 91%, 99%, 91%, and 98%,
respectively. ROC analysis showed that the PSVs were significantly better
than EDVs and ICA/CCA ratios in detecting 30% and 50% restenosis.
Conclusions: The mean PSVs of a normal ICA distal to CEA patching were
higher than normal nonoperated ICAs, therefore, standard duplex velocities
criteria should be revised after CEA with patch closure.Progression of internal carotid artery stenosis in patients with peripheral
arterial occlusive disease
Afshin S. Jahromi, Catherine M. Clase, Robert Maggisano, Robin Bailey,
Hussein A. Safar, Claudio S. Cina`
Objectives: To study the risk factors and rate of progression of asymptom-
atic carotid stenosis in patients with peripheral arterial occlusive disease.
Methods: Between July 1999 and September 2003, we studied consecutive
patients referred to a vascular laboratory for peripheral arterial occlusive
disease who had not experienced neurologic symptoms within the previous
3 years. Carotid duplex ultrasound scan (DUS) was performed at baseline
and at 6 to 12-month intervals. The internal carotid artery peak systolic
velocity (PSV) was used to determine severity of carotid stenosis. Multilevel
linear regression modeling (MLM) was used to identify the rate of progression
and risk factors for progression.
Results: For 614 consecutive patients, median follow-up by DUS was 30
(2-42) months. Patients were 73  10-years-old, and 62% were men. Mean
ankle-brachial index (ABI) was 0.79  0.24. The baseline prevalence of
carotid stenosis 50% (PSV 125 cm/second) was 22%. During follow-up,
ipsilateral amaurosis fugax, transient ischemic attacks, and strokes occurred
in 3 (0.4%), 7 (1.1%), and 5 (0.8%) patients, respectively. Overall, there was
little progression in carotid stenosis. Female gender, low ABI, and smoking
were risk factors for progression of disease regardless of severity of carotid
stenosis. Patients with 50% carotid stenosis were at greatest risk of
progression if they continued smoking and were diabetic. Prediction models
for progression of carotid stenosis given a baseline PSV and patient risk
factors were constructed.
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carotid stenosis. The average rate of progression of stenosis over 2 years is
not significant but greater in diabetic patients with baseline stenosis >50%
who continue smoking. Rescreening by serial DUS should be limited to
high-grade stenosis and follow-up performed at an interval of 1-2 years.Mesenteric revascularization: management and outcomes in the United
States, 1988e2006
Marc L. Schermerhorn, Kristina A. Giles, Allen D. Hamdan, Mark C. Wyers,
Frank B. Pomposelli
Background: Recent reports have suggested that angioplasty, with and
without stenting (PTA/S), may have a lower perioperative mortality rate
than open surgery for revascularization of acute (AMI) and chronic mesen-
teric ischemia (CMI). It is unclear if there has been nationwide adoption of
this methodology or whether there is actually a mortality benefit.
Methods: We identified all patients undergoing surgical (bypass, endarter-
ectomy, or embolectomy) or PTA/S mesenteric revascularization from the
Nationwide Inpatient Sample from 1988 to 2006. A diagnosis by International
Classification of Diseases, 9th Revision coding of AMI or CMI was required for
inclusion. We evaluated trends in management during this period and
compared in-hospital death and complications between surgical bypass
and PTA/S for the years 2000 to 2006.
Results: From 1988 to 2006, there were 6342 PTA/S and 16,071 open surgical
repairs overall. PTA/S increased steadily, surpassing all surgery for CMI in
2002. PTA/S for AMI has also increased and surpassed bypass in 2002 but
has not surpassed all surgical procedures for AMI even in 2006. The mortality
rate was lower after PTA/S than after bypass for CMI (3.7% vs 13%, P < .01)
and AMI (16% vs 28%, P < .01). Bowel resection was more common after
bypass than PTA/S for CMI (7% vs 3%, P < .01). This subgroup showed an
increased in-hospital mortality rate for both repair types (54% and 25%,
respectively).
Conclusion: PTA/S is being used with increasing frequency for revasculariza-
tion of CMI and AMI. The lower in-hospital mortality rate for patients, as they
are currently being selected, shows that PTA/S is appropriate therapy for
selected patients with CMI. Longitudinal data are needed to determine
the durability of this benefit. The greater proportion of patients undergoing
bowel resection with bypass for AMI suggests a more advanced level of
ischemia in this group, making comparison with PTA/S difficult. However,
PTA/S may be useful in selected patients with AMI and appropriate anatomy.
Further data with greater detail regarding symptomatology and anatomy will
clarify appropriate patient selection.Lipectomy as a new approach to secondary procedure superficialization
of direct autogenous forearm radial-cephalic arteriovenous accesses for
hemodialysis
Pierre Bourquelot, Jan Bijan Tawakol, Julien Gaudric, Ana Nata´rio, Gilbert
Franco, Luc Turmel-Rodrigues, Olivier Van Laere, Alain Raynaud
Background: The depth of veins can discourage surgeons from creating
radial-cephalic arteriovenous accesses for hemodialysis in obese patients.
Elevation and tunneled transposition are the two techniques that have been
described to superficialize these veins and make them accessible for cannu-
lation. Unfortunately, such manipulation of veins has potential drawbacks.
We report lipectomy, a new technique that removes subcutaneous fat and
does not mobilize the vein.
Methods: This single-center prospective study included 49 consecutive
patients (17 men, 32 women) who underwent second-stage lipectomy after
creation of a radial-cephalic fistula. Mean patient age was 54 years, 36% had
diabetes, and the mean body mass index was 31  5.6 kg/m2. Subcutaneous
fatty tissues were removed after two transverse skin incisions under regional
anesthesia and preventive hemostasis. Cannulation was first allowed 1
month later, after clinical and color duplex ultrasound evaluation. Technical
success was defined as the ability to remove the fat and to palpate the
patent vein immediately under the skin at the end of the operation. Clinical
success was defined as the ability to perform at least three consecutive dial-
ysis sessions with two needles. All patients were checked systematically
every 6 months by the surgeon.Results: Technical and clinical success rates were 96% (47 of 49) and 94% (46
of 49), respectively. Mean vein depth decreased from 8  2 to 3  1 mm
according to duplex ultrasound imaging. The mean vein diameter increased
from 6  1 to 8  2 mm. In one patient, vein tortuosity that was overlooked
required conventional repeat tunneling. One extensive hematoma resulted
in loss of the fistula. One patient died before the fistula could be used.
Primary patency rates were 71%  7% and 63%  8% at 1 and 3 years, respec-
tively, and secondary patency rates were 98%  2% and 88%  7%. Delayed
complications were treated by surgery (n = 7) or by endovascular procedures
(n = 10).
Conclusion: Lipectomy is a safe, effective, and durable approach to make
deep arterialized forearm veins accessible for routine cannulation for hemo-
dialysis in obese patients. It might even be hypothesized that incident obese
dialysis patients will eventually have the highest proportion of radial-
cephalic fistulas because they often have distal veins that have been
preserved from previous attempts at cannulation for blood sampling or infu-
sion by their fat.Laparoscopic treatment of splenic artery aneurysms
Andrea Pietrabissa, Mauro Ferrari, Raffaella Berchiolli, Luca Morelli,
Luigi Pugliese, Vincenzo Ferrari, Franco Mosca
Objectives: The purpose of this study was to report a series of 16 consecu-
tive patients who underwent laparoscopic treatment of splenic artery
aneurysms.
Methods: Over a period of 8 years, patients were selected for the laparo-
scopic option by a team of specialists that included the vascular surgeon,
the interventional radiologist, and the minimally invasive surgeon. The mean
size of the aneurysm was 32 mm and most was located at the splenic hilum.
They were twice as common in females as in males. Ultrasonography with
color Doppler function was used to define intraoperative strategy.
Results: The laparoscopic treatment entailed excision of the aneurysm or its
exclusion, usually reserved for distally located lesions. In one patient, lapa-
roscopic resection and robotic anastomosis of the splenic artery was
performed to re-establish flow to the spleen. In two patients, the intrao-
perative decision was added to combine a laparoscopic splenectomy due
to insufficient residual arterial flow to the spleen. There was no conversion,
or need for re-operation or related mortality. Analysis of intraoperative
arterial flow data avoided unnecessary splenectomy following noncritical
reduction of flow to the spleen.
Conclusions: The use of intraoperative color Doppler ultrasonography is
essential in deciding the appropriate procedure and whether the spleen
should be removed or saved. Early control of the splenic artery proximal
to the aneurysm can limit the risk of conversion due to intraoperative
bleeding. Distally located aneurysms are more difficult to manage and entail
a higher risk of associated splenectomy. The laparoscopic option offers some
advantages over the endovascular treatment in selected patients. A multi-
disciplinary approach is the key to a successful treatment of this uncommon
disease.Preprocedural hemoglobin predicts outcome in peripheral vascular
disease patients undergoing percutaneous transluminal angioplasty
Iqbal S. Toor, Rumi J. Jaumdally, Mark S. Moss, Suresh B. Babu
Background: Anemia is a risk factor for adverse outcome in patients with
symptomatic cardiovascular disease. This study assessed the association of
the preprocedural hemoglobin level with adverse outcome in patients with
advanced peripheral vascular disease (PVD) undergoing percutaneous trans-
luminal angioplasty (PTA).
Methods: Results of consecutive first-time procedures for patients with
Rutherford category 4 or 5 PVD who underwent successful nonemergency
PTA were analyzed in a retrospective cohort study. Cardiovascular risk
factors, preprocedural hemoglobin level, and angiographic data were
recorded. Preprocedural (24 hours) hemoglobin concentration was divided
into tertiles (first tertile: 10.5  0.7 g/dL; second tertile: 12.0  0.4 g/dL;
third tertile: 13.9  0.9 g/dL). Study end points were a composite of adverse
peripheral vascular events consisting of target lesion revascularization
(repeat PTA or vascular bypass operation), limb amputation, or death.
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adverse peripheral vascular outcome.
Results: A total of 101 patients (mean age, 76  10 years) were studied,
of which 54 (53%) were men, and 62 (65%) were anemic. We observed 42
events during a median of 14 months (interquartile range, 4-26 months).
Cox regression analysis found preprocedural hemoglobin in the first
tertile vs third tertile (odds ratio, 4.17; 95% confidence interval, 1.56-
11.16, P = .004), diabetes, renal failure, Rutherford category 5, and tibialrunoff were independent predictors of adverse peripheral vascular
outcome.
Conclusions: Anemia is a common comorbid condition in patients with
advanced PVD. Preprocedural hemoglobin level could be used in clinical
practice to risk stratify patients with advanced PVD who are being consid-
ered for PTA. Correction of anemia before PTA in patients with Rutherford
category 4 and 5 PVD may improve long-term outcome. Further investigation
is needed regarding the optimization of preprocedural hemoglobin.
